Required Information [The following information applies to the questions displayed below.] The December 31, 2024, unadjusted trial balance for the WolksteIn Drug Company is presented below. December 31 is the company's year-end reporting date. The following year-end adjusting entrles are required: a. Depreciation expense for the year on the equipment is $8,600. b. Salarles at year-end should be accrued in the amount of $5,480. 2. Prepare an Income statement for 2024 and a balance sheet as of December 31,2024 . Complete this question by entering your answers in the tabs below. Prepare an income statement for 2024 . Prepare a balance sheet as of December 31, 2024